Buy 3 Wide Moat Stocks With Double-Digit Near-Term Upside Potential

Core Insights - The wide moat strategy focuses on investing in companies with durable competitive advantages that ensure long-term profitability and market leadership [1][2] Group 1: Pfizer Inc. (PFE) - Pfizer is a leading drugmaker in oncology, bolstered by the acquisition of Seagen, which generated $3.4 billion in sales for 2024, reflecting a 38$7.7 billion by the end of 2027, alongside growth in non-COVID sales driving profit growth [8] - Expected revenue and earnings growth rates for Pfizer are 0.6% and 1% respectively for the current year, with a 3.4% improvement in the Zacks Consensus Estimate for earnings over the last 30 days [9] - Pfizer's forward P/E is 7.41X, significantly lower than the industry average of 12.96X and the S&P 500's 19.20X [10] - The average price target for Pfizer indicates a potential increase of 23.7% from the last closing price of $23, with a maximum upside of 43.5$71.93, indicating a maximum upside of 19.6% [14] Group 3: The Walt Disney Co. (DIS) - Disney reported steady fiscal 2025 results with year-over-year growth in revenues and earnings, although international park locations faced declines [15] - The company expects double-digit percentage growth in segment operating income for fiscal 2025, with ESPN achieving significant viewership growth [16] - Disney has transformed its streaming business into a profitable growth engine, reporting its first-ever Direct-to-Consumer operating profit in FY2024 [17] - Expected revenue and earnings growth rates for Disney are 3.8% and 15.1% respectively for the current year, with a 4.6% improvement in the Zacks Consensus Estimate for earnings [18] - The average price target for Disney indicates a potential increase of 10.9% from the last closing price of $112.66, with a maximum upside of 31.4% [19]